// startup autopsy

Sloning BioTechnology

Gene synthesis pioneer absorbed before reaching commercial scale

marketfitAcqui-hire

Fatal mistake: Focused on building proprietary technology without securing enough commercial partnerships to justify independent growth.

Founded	2000
Closed	2008
Country	Germany
Sector	Biotech

50%

Key Events Timeline

2000-01-01

FOUNDING

Sloning BioTechnology founded in Germany to develop proprietary gene synthesis platform.

2005-06-01

FUNDING

Raised early-stage funding to advance gene synthesis technology platform.

2007-01-01

FUNDING

Secured final round of $10.69M to commercialize technology, last known funding event.

2008-06-01

SHUTDOWN

Acquired by strategic buyer; independent operations ceased as company could not scale commercially.

Full Analysis

Analyst plan

Documented cause

Sloning BioTechnology developed a proprietary gene synthesis platform but failed to achieve commercial viability and scale. The company operated in a capital-intensive biotech niche dominated by larger, well-ca...

pitalized competitors with established market positions. Despite possessing differentiated technology, Sloning struggled to generate sufficient revenue traction to sustain operations independently. Th

Verified lesson

“...”

Unlock full lesson →

€25M

Peak valuation

HypeCycle · MoatType · ResearchTags

Sloning BioTechnology raised €10.69132M before focused on building proprietary technology without securing enough commercial partnerships to justify independent growth. ended it. See the documented cause, verified lesson and all failure signals.

Unlock full analysis →Create free account

See all plans·Analyst plan — €149/mo